Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals
Previously it was shown that an N-terminal tau fragment (NT1) measured in plasma can differentiate individuals with Alzheimer’s disease from healthy controls. Here the authors show that plasma levels of NT1 can associate with future cognitive decline in cognitively normal elderly individuals.
Guardado en:
Autores principales: | Jasmeer P. Chhatwal, Aaron P. Schultz, Yifan Dang, Beth Ostaszewski, Lei Liu, Hyun-Sik Yang, Keith A. Johnson, Reisa A. Sperling, Dennis J. Selkoe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e6552d7e8ff43c699163b028de8f4b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Hanna Trzeciakiewicz, et al.
Publicado: (2020) -
Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Marlies Gijs, et al.
Publicado: (2021) -
Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)